Inflammation Research Erlangen’s Post

View profile for Inflammation Research Erlangen, graphic

Explore the world of inflammation research - Dive into the Immunoverse and learn about our discoveries

At the heart of scientific innovation, our interdisciplinary groups and the IMPRS Physics and Medicine at Max Planck Institute for the Science of Light and the Max-Planck-Zentrum für Physik und Medizin are working together to unravel the mysteries of the human body. Their interdisciplinary collaboration provides groundbreaking insights into the complex immune system. This extremely exciting research provides latest insights into the human immune system in order to jointly cure chronic inflammatory and autoimmune diseases. FAU Erlangen-Nürnberg Universitätsklinikum Erlangen #InnovationInHealth #PhysicsAndMedicine #InflammationResearch #ErlangenScience #MedicalResearch #ChronicDiseaseCure #MaxPlanckScience

IMPRS Physics and Medicine 🤝 Max-Planck-Zentrum für Physik und Medizin 📽️ 👀: “The aim of this graduate school is to educate and train a new generation of scientists who use methods from physics to do fundamental research in medicine.” The International Max Planck Research School - Physics and Medicine (IMPRS-PM) is a highly innovative new graduate program at the Max-Planck-Zentrum für Physik und Medizin (MPZPM), an interdisciplinary joint research center of the Max Planck Institute for the Science of Light (MPL), the FAU Erlangen-Nürnberg (FAU) and the Universitätsklinikum Erlangen (UKER). In collaboration with FAU and UKER, IMPRS-PM offers MSc stipends and PhD positions, excellent career development opportunities and a structured interdisciplinary curriculum. Find more information about the IMPRS-PM, the application process and contacts here! 👉 https://lnkd.in/dACaBZ38 #MPZPM #Research #Physics #Medicine

Michael Moser

Data Scientist at Siemens Healthineers | PhD in particle physics

2mo

Hope you can also take a look into functional autoimmune diseases, eg PAIS + associated :)

Like
Reply

To view or add a comment, sign in

Explore topics